Back to Market Feed

Product Information

CRESEMBA 186 MG CAPSULE is a brand product labeled by Astellas Pharma US, Inc., priced at $113.9789 per EA under NDC 00469052002. Its NADAC has been published 192 times since Dec 21, 2022.

FDA first approved this application on Mar 6, 2015.

CRESEMBA 186 MG CAPSULE

isavuconazonium sulfate
$113.9789per EA

Strength

100 mg/1

NDC

00469052002

Classification

Brand

Dosage Form

CAPSULE

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

ISAVUCONAZONIUM SULFATE

Approval Type

New Drug (NDA)

FDA Application

NDA207500

FDA Approved

3/6/2015

On Market Since

11/4/2015

Pharmacological Classes

Azole Antifungal
Azoles
Cytochrome P450 3A4 Inhibitors
Organic Cation Transporter 2 Inhibitors
P-Glycoprotein Inhibitors

Price Statistics

The NADAC for CRESEMBA 186 MG CAPSULE has been published 192 times since Dec 21, 2022, and over the history we have for it it has risen 17.6%. The table below summarizes its recorded NADAC range and movement.

Current price$113.9789 per EA
All-time high$114.1261 (Jun 10, 2026)
All-time low$96.8884 (Dec 21, 2022)
52-week high$114.1261
52-week low$110.7541
Median price$108.1127
Average price$107.8478
Largest weekly change+6.0% (Jan 25, 2023)
Weeks tracked192
Tracking sinceDec 21, 2022

Price History

1W

-0.1%

1M

-0.1%

3M

-0.1%

6M

-0.1%

1Y

+2.9%

3Y

+11.7%

5Y

N/A

All

+17.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the isavuconazonium sulfate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Related Drugs

Same classification

LOTRIMIN AF 2% POWDER
Brand
11523091901•Bayer HealthCare LLC
$0.0487
per GM
REMEDY ANTIFUNGAL 2% CREAM
Brand
53329016204•Medline Industries, LP
$0.0489
per ML
MICRO-GUARD 2% POWDER
Brand
11701003816•Coloplast Manufacturing US, LLC
$0.0573
per GM
VANDAZOLE VAGINAL 0.75% GEL
Brand
00245086070•Upsher-Smith Laboratories LLC
$0.3235
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096301•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096307•Bayer HealthCare LLC
$0.3549
per GM
LOTRIMIN AF 1% CREAM
Brand
11523096305•Bayer HealthCare LLC
$0.5097
per GM
FUNGOID 2% TINCTURE
Brand
00884029301•Pedinol Pharmacal, Inc.
$0.5848
per ML
TIAZAC ER 180 MG CAPSULE
Brand
00187261330•Bausch Health US LLC
$1.5060
per EA
TIAZAC ER 180 MG CAPSULE
Brand
00187261390•Bausch Health US LLC
$1.5060
per EA

Frequently asked questions

What is the NADAC price of CRESEMBA 186 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for CRESEMBA 186 MG CAPSULE, manufactured by Astellas Pharma US, Inc., is $113.9789 per EA (NDC 00469052002), effective Aug 19, 2026.

How has the price of CRESEMBA 186 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for CRESEMBA 186 MG CAPSULE has risen 17.6%. It has been tracked across 192 weekly CMS publications since Dec 21, 2022.

What are the highest and lowest recorded NADAC prices for CRESEMBA 186 MG CAPSULE?

Since Dec 21, 2022, the NADAC for CRESEMBA 186 MG CAPSULE has ranged from a low of $96.8884 (Dec 21, 2022) to a high of $114.1261 (Jun 10, 2026), with a median of $108.1127 per EA.

Are there cheaper alternatives to CRESEMBA 186 MG CAPSULE?

No other NADAC-published product currently shares the active ingredient and strength of CRESEMBA 186 MG CAPSULE in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures CRESEMBA 186 MG CAPSULE?

CRESEMBA 186 MG CAPSULE (NDC 00469052002) is labeled by Astellas Pharma US, Inc., and CMS classifies it as a brand product.